Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |